** = Publications listed in SCI/SSCI/Pubmed
** Kirchhoff, E; Schneider, V; Pichler, G; Reif, P; Haas, J; Joksch, M; Mager, C; Schmied, C; Scholl, W; Pichler-Stachl, E; Gold, D
Hexoprenaline Compared with Atosiban as Tocolytic Treatment for Preterm Labor
GEBURTSH FRAUENHEILK. 2022; 82(8): 852-858.
Doi: 10.1055/a-1823-0176
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kirchhoff, E; Schneider, V; Pichler, G; Reif, P; Haas, J; Joksch, M; Mager, C; Schmied, C; Scholl, W; Gold, D
Comparison of tocolytic Therapy with Hexoprenaline and Atosiban in premature Labor
GEBURTSH FRAUENHEILK. 2021; 81(06):E16-E17.
Doi: 10.1055/s-0041-1730485
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Ulrich, D; Schneider, V; Pichler, G; Haas, J; Culea, V; Joksch, M; Mager, C; Schmied, C; Lakovschek, IC; Lang, U; Reif, P
Neonatal Outcome After Hexoprenaline Compared with Atosiban After Preterm Premature Rupture of Membranes
J FETAL MED. 2019; 6(4): 171-176.
Doi: 10.1007/s40556-019-00225-7
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Kollmann, M; Klaritsch, P; Martins, WP; Guenther, F; Schneider, V; Herzog, SA; Craciunas, L; Lang, U; Obermayer-Pietsch, B; Lerchbaum, E; Raine-Fenning, N
Maternal and neonatal outcomes in pregnant women with PCOS: comparison of different diagnostic definitions.
Hum Reprod. 2015; 30(10):2396-2403
Doi: 10.1093/humrep/dev187
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG